ZBH Zimmer Biomet Holdings Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ZBH

Price (delayed)

$127.29

Market cap

$26.6B

P/E Ratio

115.72

Dividend/share

$0.96

EPS

$1.1

Enterprise value

$31.92B

Zimmer Biomet is a publicly traded medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of ...

Highlights
The debt has declined by 19% year-on-year
ZBH's quick ratio has soared by 60% YoY but it is down by 5% QoQ
The EPS has contracted by 43% YoY and by 17% from the previous quarter
The net income has declined by 42% year-on-year and by 17% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.zimmerbiomet.com/
Peers: BSX SYK COO XRAY

Key stats

What are the main financial stats of ZBH
Market
Shares outstanding
208.98M
Market cap
$26.6B
Enterprise value
$31.92B
Valuations
Price to earnings (P/E)
115.72
Price to book (P/B)
2.22
Price to sales (P/S)
3.84
EV/EBIT
62.78
EV/EBITDA
22.25
EV/Sales
4.6
Earnings
Revenue
$6.94B
EBIT
$508.5M
EBITDA
$1.43B
Free cash flow
$838.5M
Per share
EPS
$1.1
Free cash flow per share
$4
Book value per share
$57.28
Revenue per share
$33.11
TBVPS
$35.41
Balance sheet
Total assets
$21.07B
Total liabilities
$9.04B
Debt
$5.7B
Equity
$12.02B
Working capital
$2.07B
Liquidity
Debt to equity
0.47
Current ratio
1.88
Quick ratio
0.75
Net debt/EBITDA
3.71
Margins
EBITDA margin
20.7%
Gross margin
70.9%
Net margin
3.3%
Operating margin
10%
Efficiency
Return on assets
1.1%
Return on equity
1.9%
Return on invested capital
4.9%
Return on capital employed
2.7%
Return on sales
7.3%
Dividend
Dividend yield
0.75%
DPS
$0.96
Payout ratio
87.3%

ZBH stock price

How has the Zimmer Biomet Holdings stock price performed over time
Intraday
-0.39%
1 week
1.62%
1 month
2.97%
1 year
5.65%
YTD
-0.16%
QTD
-0.16%

Financial performance

How have Zimmer Biomet Holdings's revenue and profit performed over time
Revenue
$6.94B
Gross profit
$4.92B
Operating income
$696.3M
Net income
$231.4M
Gross margin
70.9%
Net margin
3.3%
The net margin has declined by 44% year-on-year and by 18% since the previous quarter
The net income has declined by 42% year-on-year and by 17% since the previous quarter
Zimmer Biomet Holdings's operating margin has decreased by 21% YoY and by 20% QoQ
Zimmer Biomet Holdings's operating income has decreased by 19% YoY and by 19% QoQ

Growth

What is Zimmer Biomet Holdings's growth rate over time

Valuation

What is Zimmer Biomet Holdings stock price valuation
P/E
115.72
P/B
2.22
P/S
3.84
EV/EBIT
62.78
EV/EBITDA
22.25
EV/Sales
4.6
The EPS has contracted by 43% YoY and by 17% from the previous quarter
ZBH's P/E is 13% higher than its last 4 quarters average of 103.1
The stock's P/B is 12% above its last 4 quarters average of 2.0
ZBH's equity is down by 5% year-on-year
ZBH's price to sales (P/S) is 10% higher than its last 4 quarters average of 3.5 and 4.3% higher than its 5-year quarterly average of 3.7

Efficiency

How efficient is Zimmer Biomet Holdings business performance
Zimmer Biomet Holdings's return on equity has decreased by 41% YoY and by 17% QoQ
The ROA has contracted by 35% YoY and by 15% from the previous quarter
The ROS has contracted by 25% YoY but it has grown by 6% from the previous quarter
The ROIC has increased by 11% QoQ but it has decreased by 9% YoY

Dividends

What is ZBH's dividend history
Dividend details
DPS
$0.96
Dividend yield
0.75%
Payout ratio
87.3%
Recent dividends

Financial health

How did Zimmer Biomet Holdings financials performed over time
The total assets is 133% higher than the total liabilities
ZBH's quick ratio has soared by 60% YoY but it is down by 5% QoQ
The current ratio has grown by 33% YoY but it has contracted by 5% from the previous quarter
The debt is 53% smaller than the equity
The debt has declined by 19% year-on-year
The debt to equity has declined by 16% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.